• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠溶剂型麦考酚钠在狼疮性肾炎中的药代动力学研究方案(POEMSLUN):一项开放标签、随机对照试验。

A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial.

机构信息

Department of Renal Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.

出版信息

BMJ Open. 2013 Aug 7;3(8):e003511. doi: 10.1136/bmjopen-2013-003511.

DOI:10.1136/bmjopen-2013-003511
PMID:23929919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3740249/
Abstract

INTRODUCTION

Mycophenolate sodium, an enteric-coated tablet (EC-MPS), is as effective and safe as mycophenolate mofetil (MMF) in preventing transplant rejection. EC-MPS and MMF improve the outcome of severe lupus nephritis (LN) and have fewer side effects than pulsed intravenous cyclophosphamide. Blood concentrations of mycophenolic acid (MPA), the active metabolite of EC-MPS, vary between participants despite fixed dosing. Interpatient variability has been studied in transplantation, but not well documented in LN. The relationship between MPA concentration and its clinical effect on LN has not been described.

METHODS AND ANALYSIS

This is a prospective, open-label, randomised controlled trial. -32 participants with LN who meet the inclusion and exclusion criteria will be randomised into two groups: one receiving a fixed dose of EC-MPS and the second, a dosing regimen that is titrated with therapeutic drug monitoring. Included participants will have blood sampled over a period of 8-12 h on three different occasions. Pharmacokinetic parameters will be calculated using non-compartmental methods.

ETHICS AND DISSEMINATION

The Human Research and Ethics Committee of the Royal Brisbane Women's Hospital have approved this study. The study is registered with Australian and New Zealand Clinical Trials Registry-ACTRN12611000798965 We planned to present the de-identified information at conferences and publish the results in medical journals.

TRIAL REGISTRATION

ACTRN12611000798965.

摘要

简介

吗替麦考酚酯钠(一种肠溶片)与吗替麦考酚酯(MMF)在预防移植排斥反应方面同样有效且安全。吗替麦考酚酯钠(EC-MPS)和 MMF 可改善严重狼疮肾炎(LN)的预后,且比脉冲式静脉注射环磷酰胺的副作用更少。尽管固定剂量给药,但 EC-MPS 的活性代谢产物麦考酚酸(MPA)在不同参与者之间的血药浓度存在差异。尽管在移植领域已经研究了个体间的变异性,但在 LN 中尚未有充分的记录。MPA 浓度与其对 LN 的临床效果之间的关系尚未描述。

方法和分析

这是一项前瞻性、开放标签、随机对照试验。-32 名符合纳入和排除标准的 LN 患者将被随机分为两组:一组接受固定剂量的 EC-MPS,另一组则采用根据治疗药物监测进行滴定的剂量方案。纳入的参与者将在三个不同时间点采集 8-12 小时的血样。将使用非房室方法计算药代动力学参数。

伦理和传播

皇家布里斯班妇女医院人类研究和伦理委员会已批准本研究。该研究在澳大利亚和新西兰临床试验注册中心(ACTRN12611000798965)注册。我们计划在会议上展示去识别信息,并在医学期刊上发表结果。

试验注册

ACTRN12611000798965。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3406/3740249/73719b2339dd/bmjopen2013003511f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3406/3740249/73719b2339dd/bmjopen2013003511f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3406/3740249/73719b2339dd/bmjopen2013003511f01.jpg

相似文献

1
A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial.肠溶剂型麦考酚钠在狼疮性肾炎中的药代动力学研究方案(POEMSLUN):一项开放标签、随机对照试验。
BMJ Open. 2013 Aug 7;3(8):e003511. doi: 10.1136/bmjopen-2013-003511.
2
Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN).肠溶剂型麦考酚钠治疗狼疮肾炎的药代动力学研究(POEMSLUN)
Ther Drug Monit. 2019 Dec;41(6):703-713. doi: 10.1097/FTD.0000000000000658.
3
Enteric-coated Mycophenolate Sodium therApy versus cyclophosphamide for induction of Remission in Microscopic PolyAngiitis (EMSAR-MPA trial): study protocol for a randomised controlled trial.肠溶包衣麦考酚钠治疗与环磷酰胺诱导显微镜下多血管炎缓解的对比研究(EMSAR-MPA试验):一项随机对照试验的研究方案
BMJ Open. 2024 Mar 11;14(3):e074662. doi: 10.1136/bmjopen-2023-074662.
4
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.在接受他克莫司治疗的维持性肾移植受者中,从霉酚酸酯转换为肠溶包衣的霉酚酸钠:临床、药代动力学和药效学结果。
Transplantation. 2007 Feb 27;83(4):417-24. doi: 10.1097/01.tp.0000251969.72691.ea.
5
Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.霉酚酸,临床药代动力学,制剂,以及评估药物暴露的方法。
Transplant Rev (Orlando). 2011 Apr;25(2):47-57. doi: 10.1016/j.trre.2010.06.001. Epub 2010 Dec 28.
6
Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil.接受肠溶包衣吗替麦考酚酯钠或吗替麦考酚酯的肾移植患者的霉酚酸代谢物谱
Transplant Proc. 2005 Mar;37(2):852-5. doi: 10.1016/j.transproceed.2004.12.186.
7
Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.霉酚酸的群体药代动力学:肾移植受者中肠溶型霉酚酸钠与霉酚酸酯的比较
Clin Pharmacokinet. 2008;47(12):827-38. doi: 10.2165/0003088-200847120-00007.
8
Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients.与霉酚酸酯相比,肠溶衣霉酚酸钠在初发心脏移植受者体内霉酚酸的药代动力学及变异性
Clin Transplant. 2007 Jan-Feb;21(1):18-23. doi: 10.1111/j.1399-0012.2006.00569.x.
9
Enteric-coated mycophenolate sodium given in combination with tacrolimus has a lower incidence of serious infections in Asian renal-transplant recipients compared with mycophenolate mofetil.与霉酚酸酯相比,在亚洲肾移植受者中,肠溶包衣的麦考酚钠与他克莫司联合使用时严重感染的发生率较低。
Int J Clin Pract Suppl. 2015 May(183):1-7. doi: 10.1111/ijcp.12660.
10
Effect of the proton-pump Inhibitor pantoprazole on MycoPhenolic ACid exposure in kidney and liver transplant recipienTs (IMPACT study): a randomized trial.质子泵抑制剂泮托拉唑对肾和肝移植受者麦考酚酸暴露的影响(IMPACT 研究):一项随机试验。
Nephrol Dial Transplant. 2020 Jun 1;35(6):1060-1070. doi: 10.1093/ndt/gfaa111.

引用本文的文献

1
Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN).肠溶剂型麦考酚钠治疗狼疮肾炎的药代动力学研究(POEMSLUN)
Ther Drug Monit. 2019 Dec;41(6):703-713. doi: 10.1097/FTD.0000000000000658.

本文引用的文献

1
Limited-sampling strategy for mycophenolic acid in renal transplant recipients reciving enteric-coated mycophenolate sodium and tacrolimus.在接受麦考酚钠肠溶片和他克莫司的肾移植受者中,霉酚酸的有限采样策略。
Ther Drug Monit. 2012 Jun;34(3):298-305. doi: 10.1097/FTD.0b013e318255cc15.
2
Pharmacokinetics of mycophenolic acid in severe lupus nephritis.霉酚酸在严重狼疮肾炎中的药代动力学。
Kidney Int. 2010 Aug;78(4):389-95. doi: 10.1038/ki.2010.170. Epub 2010 Jun 9.
3
Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients.
肠溶剂型麦考酚钠的药代动力学和药效学分析:在肾移植患者中的有限采样策略和临床转归。
Br J Clin Pharmacol. 2010 Apr;69(4):346-57. doi: 10.1111/j.1365-2125.2009.03612.x.
4
A reliable limited sampling strategy for the estimation of mycophenolic acid area under the concentration time curve in adult renal transplant patients in the stable posttransplant period.一种适用于稳定期成年肾移植患者的麦考酚酸浓度时间曲线下面积估算的可靠有限采样策略。
Ther Drug Monit. 2010 Apr;32(2):136-40. doi: 10.1097/FTD.0b013e3181cd550f.
5
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.种族/民族对狼疮肾炎治疗反应的影响:ALMS 研究。
Rheumatology (Oxford). 2010 Jan;49(1):128-40. doi: 10.1093/rheumatology/kep346. Epub 2009 Nov 20.
6
Mycophenolate blood level monitoring: recent progress.霉酚酸血药浓度监测:近期进展
Am J Transplant. 2009 Jul;9(7):1495-9. doi: 10.1111/j.1600-6143.2009.02678.x. Epub 2009 Jun 10.
7
Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial.固定剂量或控制剂量的霉酚酸酯与标准剂量或减量的钙调神经磷酸酶抑制剂:Opticept试验
Am J Transplant. 2009 Jul;9(7):1607-19. doi: 10.1111/j.1600-6143.2009.02668.x. Epub 2009 May 20.
8
Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study.霉酚酸酯治疗系统性红斑狼疮患者:一项前瞻性药代动力学研究。
Lupus. 2009 Apr;18(5):441-7. doi: 10.1177/0961203308098631.
9
Modification and validation of the Birmingham Vasculitis Activity Score (version 3).伯明翰血管炎活动评分(第3版)的修订与验证
Ann Rheum Dis. 2009 Dec;68(12):1827-32. doi: 10.1136/ard.2008.101279. Epub 2008 Dec 3.
10
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial.比较霉酚酸酯方案用于初发肾移植受者:固定剂量浓度控制试验
Transplantation. 2008 Oct 27;86(8):1043-51. doi: 10.1097/TP.0b013e318186f98a.